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[n v ivo studies have shown that hum an C5a, a po tent co m-
plem ent-derived anaphy latoxin and chem oattra cra nt, 
produ ces immediate inAamm atory reactions following in-
tradermal injection in hum an skin . At concentrations w ithin 
its potential ph ysio logic range , intraderm al inj ection ofC5a 
eli cits immediate w hea l and Aare reactio ns, in creased vas-
cular permeability, mast cell degranulation, and neutro-
phil-rich infiltrates . To assess the relative contributio n of 
interactin g ce llul ar elem ents to C5a-indu ced inAam matio n 
in no rm al hum an sk in , purified hum an C5a was tested 
intradermally in 8 patients w ith bone marrow failure (BMF). 
Reactions to C5a in patients w ith BMF were co mpared 
w ith responses at identi ca l tes t sites in hea lth y vo luntee rs 
and other pati ents w ith cutaneous disorders. Patients w ith 
BMF demonstrated sig nifi cantl y less w hea l and Aare reac-
tivity fo ll owing intraderm al injection of C5a than contro ls 
(p < 0.05 and < 0.02, respectively). In these studies, pa-
tients with the g reatest cytopenia generall y showed the least 
T he re lease of so lubl e m ed iato rs of inflam m atio n from dermal mast ce lls has been rega rded as a key elem ent in the develop m ent of cutaneo us w hea l and flare re-ac tion s. Studies in anim als have sugges ted a tWO-lllC-diato r hypothesi s to account for the di stin ct responses 
of vaso per111 ea bility and vasod ila tatio n at these sites [1 ,2]. This 
hypothesis suggests that one g roup of so lu ble mediators (e.g., 
histamine, bradyk inin) is respollsibl e for vasoperm ea bility, w hile 
another class of locall y produced agents (e. g., prostaglandin £ 2, 
prostaglandin 12) promotes vasod il atation. In subseq uent pllJr-
ma colog ic studies, the sy nerg istic acti vity of these g ro ups of me-
diators has been co nfirm ed. H owever, recent studies in animal s 
have led to an important modification of the two-mediator h y-
pothes is by demonstratin g that leukocytes, specifica ll y po lym or-
phonuclear neutrophils (PM N s), playa central role in the initi-
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cutaneous reactivity to human C5a. Biopsies of C5a test 
sites in patients with BMF revealed an absence of leuko-
cy tes in marked contrast to neutro phil-ri ch infiltrates ob-
served at test s ites in hea lth y vo lun teers. A vidin-Auorescein 
and /o r Gie l11 sa stainin g of skin biopsies revea led no di f-
ference between the number of derma l m as t cells in patients 
with BMF and sa mples of no rmal hum an sk in . In addition, 
sk in test studies with histamine (2 J-Lg) and m o rphine (5 
J-Lg) perfo rm ed to assess cutaneous vascu lar and mast cell 
responsiveness in pat ients w ith BMF, normal volunteers , 
and contro ls w ith rhiniti s revea led no signifi cant differences 
in cutaneous reactivity to these pharm acologic agents. These 
in vivo studies demonstrate that patients with BMF spe-
cifi cally exhibit decreased cutaneous reactivity to human 
C5a and suggest that neutrophil s m ake an impo rtant and 
an imm ediate contributio n to inAammato ry responses elic-
ited by this anap hy latox in . J fl llIcs l Den'l'lalo/ 88:388- 392, 
1987 
ation of vasod ilatation and vasoperm eabili ty at sites of inflammation 
in sk in 13-5 1. T hese studies showed that neu tropenic an imals 
demonstrate decreased vascular respo nses fo ll owin g intradermal 
challenge with l1licrob ial infl ammato ry stimuli o r leuk ocyte che-
m o tacti c facto rs despite norma l responsiveness to vasoacti ve me-
di ators such as hi stamin e o r brad yk inin. Furthermore, reconsti-
tuti o n of PMNs by transfusion was associated w ith the restoration 
of cutaneous vascular responses in previously neutropen ic, hy-
poresponsive anima ls 13]. Thus, these studies in ex perim ental 
anim als have su ggested that PMNs play an impo rtant role in the 
regulati on of vascul ar responses at sites of cutaneous inflamma-
tion. 
We ha ve recentl y characte ri zed the clinical and histologic re-
actions produced by intradermal injection of purified hum an C5a 
in hum an sk in in vivo 16). In these studies, immediate whea l and 
fl are reactions welle associated w ith PMN-rich infiltrates that de-
veloped wi thin minutes at C5a inj ection sites. Reactions at these 
sites were acute alld not associated with later clinica l o r histologic 
alteratio ns. To assess the relative co ntribution of these cells to 
immediate anaph ylatox in-induced infl ammation in human sk in , 
we have quantitated th e cutan eous reactivity of human C5a and 
other solu ble mediators in patients w ith bo ne marrow fa ilure 
(B MF). Responses in these individuals have been compared w ith 
those documented at iden ti ca l test sites in hea lthy vo lun teers and 
sk in disease con tro l subj ects. These human studies extend prior 
observations in experim ental animals and suggest that PMNs 
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make an important contribution to th e immed iate cutan eous vas-
cular and inflamm atory reacti ons eli cited by this anaphylatoxin . 
M ETHODS 
SUbjects Human C 5a w as tes ted intraderm all y in 8 patients 
with BM F (2 m ales, 6 fem ales, ages 18-67 years, m ean age 46. 1 
yea rs). T his g roup included patients w ith aplas tic an emia (n = 
4), hypoplas ti c pancyto penia (n = 2), immune pan leuk o penia (n 
= 1) , and m yelofibrosis (n = 1). All BMF patients w ere evaluated 
by clini ca l, labo ratory, and bone m arro w studies under an in-
ves ti gative protocol of th e C linica l H emato logy Branch o f the 
National H eart, Lung , and Blood Institute befo re their parti ci-
pation in thi s study. T he total neu trophil and band leukocy te 
count was less than 1000/mm 3 in 4 o f th ese. patients and less th an 
2000/mm3 in the o thers; platelet coun ts were less than 50,OOO/mm3 
in 5 patients, less than 100,OOO/ mm 3 in 2, and 201,OOOh11ln3 in 
the indi v idu al w ith immune panl eukopenia. N o ne o f these BMF 
patients had received an tihistamines, nonstero idal anti-inflam-
mato ry agents, or other m edi cati ons kn own to alter cutaneous 
reactivit y to C 5a fo r > 96 h before skin tes tin g . C5a- indu ced w heal 
and flare responses in these BMF patients were compared w ith 
reactio ns d ocum ented in no rm al vo lunteers (n = 6) and skin 
disease co ntro l subj ects (n = 3, diagnosis: dermatitis herpetifo r-
mis). Two platelet-suffi cient ad ul t patients w ith the C hcdiak-
Higashi syndrome-a rare hereditary disease charac terized by im-
paired neu tro phiJ chemotaxis and degranulatio n f7 ,8]-were also 
included as contro l subj ects in this s tudy . To assess cutaneous 
vascular and m as t cell responsiveness, patients with BMF were 
also chall enged intraderma ll y w ith histamin e (2 J.Lg) and m orphin e 
(5 J.Lg). T he reactions to these pharmacologic m ediato rs in patients 
with BMF tes ted with C 5a w ere compared with res po nses at 
identi ca l tes t sites in no rm al vo lunteers (n = 11) , additional pa-
tients with B M F enroll ed in the sam e in ves ti gat ive p ro toco l but 
not challenged w ith human C 5a (n = 11 ), and contro ls w ith a 
docum ented history o f all erg ic o r vaso m o to r rhiniti s (n = 8 and 
n = 3, respectively). All subjects gave their in fo rm ed consent 
before participating in th ese investi ga tive studies . All skin test 
reagents w ere shown to be pyrogen- and hepatitis B surface an-
tigen-free befo re their use in hum ans (Pharm aceuti ca l D evelop-
ment Div ision, N atio nal Institutes o f H ealth , B ethesda, M ary-
land). 
Human CSa The hum an C 5a used in these studies was purifi ed 
to homogeneity fro m the citrated plasma o f kn own hea lthy do-
nors using a previo usly described technique [9.1. This m aterial has 
been shown to dem onstrate the characte ri stic immunochemi ca l 
and biologic activity o f hum an C5a [9 ,10]. The pH of human 
C5a used in these studies was 7.21. 
Skin Tests Intradermal skin tests were perfo rm ed on the vo lar 
forearms of all subjects usin g syringes fitted w ith 27-gauge needles. 
Mi llimeters o f wheal and fl are at skin tes t sites w ere record ed as 
the m ean o f the m aximal respo nse and its respective perpendi cul ar 
diam eter at selected time intervals after the intraderm al inj ectio n 
of various m ediators. In this study, subj ects w ere tes ted with 
human C 5a at doses rang in g between 50-200 ng . D oses o f 100 
ng and 200 ng w ere selected fo r co mparison o f reactivity between 
contro ls and BMF patients because these doses reliab ly elicit wh ea l 
and flare reactions and are at a hi g h eno ugh concentrati o n so that 
min o r differences in cutaneous reacti vity w ould no t be amp li fi ed . 
All subj ects challenged with human CSa w ere also tes ted w ith an 
identi ca l vol ume of ste r il e saline diluent control [6]. 
Skin Biopsies T hree-millimeter pun ch bio psies of sk in from 
C5a inj ecti on sites were o btained fro m 2 patients with BMF and 
4 healthy volun teers 20 min after the intradermal inj ection o f 
anap hylatoxin (50-100 ng of C 5a). B io psies w ere fixed in '10 % 
neutral forma lin , washed w ith phosphate-buffered sa line o ver-
ni ght, deh ydrated in g raded concentratio ns o f isopro py l alcoho l 
(50, 70, and 80%, l-h incubation in each so lu tion with gentl e 
stirrin g), embedded in glycol m eth acrylate, and processed fo r 2-
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J.Lm plastic sectio ns (personal comm unication , Mi chael H arvey, 
America n Histo Labs, Ga ithersburg, M aryland) . All biopsies were 
stained w ith hem atoxy lin and eosin and Gi emsa. Additio nal bio p-
sies w ere obtained fro m the skin o f 11 patients w ith BM F (in-
cludin g 3 subj ects tested with C 5a and 4 tes ted with histamine 
and m o rphin e) du rin g the course o f these studies and were ex-
amined with av id in-fluorescein andlor G iem sa fo r the presence 
o f derm al mast cell s [111. T o quantitate derm al m as t cells in 
normal hum an skin (n = 4) as well as ski n from patients with 
BMF (n = 8), the average num ber of avidin - flu o rescein positive 
cell s per 40 x mi crosco py field s was determined by countin g . 
Sim ilar counts o f dermal m as t cells w ere m ade on Giemsa-stained 
2-J.L m plastic sectio ns of skin bio psies fro m subj ects in these two 
stud y g rou ps. 
RESULT 
Skin Tests Patients with BMF dem onstrated immediate and 
dose-related w heal and flare reacti ons fo llowing intraderm al chal-
lenge w ith hum an C 5a. H o wever, w hen co mpared with hea lth y 
vo lun teers and skin disease contro ls, reactio ns fo llo win g intra-
d erm al injection o f hum an C5a in patien ts with BM F were re-
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Figure 1. Cutaneous reactions follow in g t1;e intradermal injection of 200 
ng of human CSa in normal volunteers and skin disease controls (n = 9) 
(so lid circles) and BMF patients (n = 7) (o pell circles) . T he mean ( :!: SEM) 
whea l and Aare diameter elicited by the intraderm al injection of 200 ng 
of hum an CSa was significantl y reduced in BMF patients in this study (p 
< 0.05 and p < 0.02, respecti vely, for all time poin ts). Skin test responses 
of norm al volunteers and skin disease contro l subj ects are presented as 
summary data because there were no differences in wheal or Aarc reactivity 
in these subj ects. 
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du ccd (Fi g 'I) , Thc mcan whca l diam eter eli c itcd b y th e intra-
dcrm al injectio n o f 200 ng o f hum an C 5a was sig nifi cantl y rc-
du ccd in p ati ents w ith 13M F a t a ll tim e p o in ts in this s tud y 0) < 
0.05). Likew ise, 13MF p ati cnts d evelo pcd sig nifi cantly less Aare 
fo ll owin g in t radermal challen ge w ith 200 ng o f human C 5a 0) < 
0.02 fo r a ll tim c po ints) . In these s tudi cs, pa ticnts w ith th e g reates t 
cyto peni a gcn cra ll y showed th e Icas t cutaneo us rcacti v ity to hu-
m an CSa. T hi s trcnd applied to bo th th c periph cral blood ncU'-
tro phil and plate lc t co unts in th ese pati ents w ith 13MF but was 
m o re cl osely associated w ith th e to ta l number o f th e fo rm er cell 
ty pe (Fi g 2) . To m o re clearl y d efin e the ro le o fPMN s and pla te le ts 
in CSa-e li c ited cutaneo us rcactio ns in hum ans, w e direc tl y qu an-
tita ted whca l and Aare res pon ses in 1 p ati ent with il11mun e pan-
leuk openia (n eutro phil s + b and s 81/ 111m3 ; pl ate le ts 
201,000/ 111111 3) and 2 pl a te le t-su ffi c ient adults (pla tel e ts = 198, 000 
mm .1 and 3 14,000 mm") w ith th e C hcdi ak-Hi gas hi sy ndro m e . All 
3 of these subj ec ts d em o nstrated d ecreased immediate wh ea l and 
Aare reactio n s fo ll ow in g intradermal chall en gc with hum an C 5a . 
To d e termin e w hether pa ti ents w ith 13 MF ex hibit a gen era lized 
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Figure 2. C utaneous reacti ons fo llowing th e intraderm al injection of 200 
ng of hum an Csa in norm al volunteers and skin disease contro ls (opfl/ 
Iriallg /rs) and E M F patients w ith va ryi ng degrees of neutropenia 1 PMN 
+ bands 1000-2000 (n = 4). opell cirrlrs; PMN + bands < 1000 (n = 
3), solid cir(lesl· Patients with th e grea tes t cytopenia showed th e least 
reacti vity to hUl11 an CSa . 
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Figure 3. A . Whea l (solid W /IIIIIIlS) and Ra re (( 'PCII m /llllllls) responses in 
EMF p:1 tients and control subj ec ts 15 min fo ll ow in g intr:1 de rm al challenge 
with histamin e (2 f.Lg), There were no signifi cant d iffe n:nces in cutaneous 
reacti vity between these groups o f subjects, thus demonstratin g that EM F 
patients ex hibit norm al cu taneous vascular responsiveness to this phar-
macologic agent. B, Whea l (solid (0 /1111111 .1) and Rare (op e ll W /IIIIIIIS) responses 
in J3 MF patients and contro l subjects 15 min fo ll ow in g in tradermal chal-
lenge with morphine (5 f.L g). There were no s i g nifi~a nt differences in 
cutaneous react ivit y between these groups of subjec ts, thus demonstrating 
th at I3MF patients ex hi bit norm al cutaneo us mas t ce ll responsiveness. 
dec rease in cu ta neous vascul a r react iv ity o r 1ll3s t ce ll respo nsive-
ness, patients and contro ls were tcs ted intraderm311 y with his-
t3min c (2 /-Lg) 3nd m o rphin e (5 /Lg) , As sho wn in Fi g 3A and B, 
res pectively, th ere we re n o sig nifi cant differen ces b etween whea l 
and Aare res po nses in pa tients w ith 13MF and contro l subj ects 
fo ll ow in g intrad erm al ch 311 en ge w ith e ith er hi sta mine o r m or-
phin e. These res ults de m o nstra te th a t 13MF pa ti ents ex hibit nor-
mal cutan eous respo nsiveness to a ph arm acologic ago nist (i. e., 
his tamin e) as we ll as a l11 as t ce ll secre ta gogue (i.e., m o rphine) . 
The decreased cutaneo us reacti v ity to human C5a in p ati ents with 
13M I: is thu s specifi c and d oes not represent a gcn era li zed redu c-
ti o n in skin tes t res po nsiveness . Skin tes ts in th ese pati ents and 
contro ls sugges t tha t cellul a r cl em ents in periph eral blood m ake 
an impo rtant and an imm edia te co ntributi o n to inA al11m atory 
reacti o ns e li cited b y hum an C 5a in human skin in v ivo. 
Skin Biopsies T o furth e r in ves ti ga tc th ese clini ca l o bserva ti o ns, 
bio psies werc o bta incd fr o l11 2 pat ients w ith EMF fo ll owin g the 
intrad ermal inj ec tio n o f hum an CSa and compared with similar 
bi o ps ies frolll tes t sites in n o rmal co nt ro ls. As show n in Fi g 4A 
and B, d erm al ed e m a was fo und w ith o ut associated leukocytic 
infiltra tes a t CSa injec ti o n s ites in p a ticnts with 13MF. These find-
in gs d iffe r sig nifi ca ntl y fro l11 the n eutro phil-ri ch leukocy ti c in-
filtra tes and s ites o f leuk ocytoclas is o bserved at inj ec ti o n sites in 
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Figure 4. A alld B, A skin biopsy o b-
tai ncd fro m a BMF patient 20 min fo llow-
ing the intrade rmal injec tion of 100 ng o f 
hum an C5a revea ls mild dermal ede ll1 a 
with o ut associated icukocy ti c in fi lt rates 
within and a round blood vessels (o ri g in al 
mag nifi ca tio n x 85 and 2 15. respec ti vci y; 
hc matoxylin-cos in ). C !llId D, A skin bi -
opsy o btained from a no rmal vo lunteer 20 
min fol lowin g thc intraderma l injection o f 
50 ng of hUll1an C5a revea ls dermal cde ll1 a, 
a marked neutrophil - ri ch perivascu la r leu-
kocytic inflltratc, focal Icukocytoclasis, and 
cndo theli al cdl swellin g (o ri g inal m ag ni -
fi catio n x 85 and 2 15, respecti vely; he-
matoxylin-eos in ). O m studi es in hllll1 'lIl 
ski n in vivo ha ve show n tilat intrade rm al 
cha ll cnge w ith C 5a prod uces no tab le his-
to logic alterat io ns at dosl's as low as lOn g 
(10 - 12 m o les); tcs t s ites recei ving C5a at 
doses g rea te r than 20 ng revea l virtu all y 
idcnti ca l hi sto lo g ic alte ratio ns with nO ev i-
dence of desensitiza tio n at doses as hi g h 
as 200 ng. 
normal vo lunteers (Fi g 4C, D) . Fu rth erm o re, av idin-fluo rescein 
and/o r C iemsa stainin g of skin biops ies from 11 p:ltients w ith 
E MF reveJ led dc rm al m as t cells that were indistin g ui shable in 
number o r distributio n fi'o m those docum cnted in skin fro m healthy 
volunteers. Specifi ca ll y, th ere WJS no differen ce in th e number 
of avidin-fluorescein positi ve de rnul mast cell s in 40 X mi cros-
copy fie ld s of skin fro m pati cnts with BMF and sa mples o f no rmal 
human skin (4.83 ± 0 .49 vs 5.32 ± 0.27, respective ly; p > 0.20) . 
T his findin g WJS furt her supportcd by co unts of m ast ce ll s in 
Gie msa-stained 2-}.(.m pl as ti c sectio ns of skin biopsies from these 
two stud y g ro ups. The res ults o f th ese m o rph o log ic studies in 
pa tients with BMF are in agreelllent with the in vivo tes ts of mast 
ce ll responsiveness described above. 
D ISCUSS IO N 
Studies in experim ental anima ls havc suggested that PMN s are 
importa n t el em ents in the regulati o n of immed iate vascul ar re-
sponses at infl amm ato ry sitcs in sk in [2-51. Additio nal ev idence 
in suppo rt o f thi s co ncept has been deve lo ped in hamster chec k 
pouch studi es, whi ch have show n that sites o f mi crovascular 
permea bility co rrespond to areJS in postcapill ary venul es w here 
PMNs Jdhere to end o theli al cells in res po nse to applied che-
motactic facto rs 11 2 1. However, this iss ue has not been directl y 
addressed in vivo by cutaneous chall cnges w ith C5a and rclevant 
pharm aco logic agcnts in hum ans w ith cy to pcni a secondary to 
E MF. H.ecentl y, wc studicd a large number of patiellts w ith BMF 
w ho wcrc trea tcd acco rdin g to an investi ga tivc protoco l with dail y 
i. v. infusio ns of horse :lI1tith y mocyte g lo bulin (ATG). Subse-
quent to th esc infusio ns, th ese patien ts deve loped circulatin g im-
mune co mplexes, m ark ed decrcases in se rum co mpl cm ent com-
ponents, and hi g h levels o f C3a , w hi ch were co nco rda llt w ith the 
appearance of thc sig ns and sympto ms of sc rum sickncss 113'1. 
Howevcr, th e plasn13 conccntratio ns ofC3a in th ese patients were 
unacco mpanicd by altcrations docum ented in anim als o r iso latcd 
o rgans ex poscd to hi g h levels of this anaph ylatox in 11 4, 15 1. This 
observa ti o n pro mpted additi onal studies to assess th e relati ve con-
tribution o f intcract in g cellular e lemcnts in C5a- mcdiated cuta-
neous inflammatio n in vivo. T hese studics show that patients with 
B MF dcm onstrate sig nifi ca ntl y redu ced cutanco us reactivity to 
human C5a , w hich rcprescnts a spec ifi c h ypo respo nsiveness to 
t his mediato r within th c contcxt of th eir cy topenia . Similar o b-
serva tio ns wc re m ade in 2 o ther patients with BMF w ho were 
not form all y in cluded in this repo rt du e to intercurrent illnesses 
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and /or m edicati o ns. In thi s stud y, pati ents w ith the g reatest cy-
to penia generall y showed th e least reactivity to hum an C5a. Al-
though th e exact role of platelets in C5a-eli cited cutaneous I'C-
acti ons in hum ans has no t been prccisely dcfi ned , o ur studies in 
I patiellt w ith immune panlcuk o penia JS wcll as 2 indi viduals 
w ith th e C hcdiak-Hi gJshi syndro m e dem o nstrate that cutaneo us 
res ponsiveness to C 5a is clearly redu ced in platel et- su ffi cicnt sub-
jects w ith either neutro pen ia o r impaired neutro phil fun ctio n . 
Rcccnt studies in rabbits have directl y exami ned th e re lat ionship 
bctwcen neutrop hil and platelet infi ltration at sites of cutaneo us 
infl Jmm ation pro du ccd by thc inj ecti on of zy m o an-activated 
pIaSIl1 J, synthetic leukocy te chemoa ttra ctants , endotoxin , or killcd 
bactcria . T hese studies showed that platele t dcposition at these 
inflamma to ry sites co rrelated w ith neutro phil infiltration and th at 
platelet depos iti o n d id no t occur in neutropeni c ye t platelet-suf-
fi cient anim als 11 6 ]. T he exact m echanism b y w hi ch PMNs pro-
m o te w hea l and flare res ponsiveness fo llowin g intraderm al in-
jection o f C5:1 in hum Jns is no t known. T his activ ity Ill ay be 
related to th c secrctio n o f vasoactive substanccs by PM N s o r d ue 
to their stimulati on of o ther ce ll s, such as cndotheli al cells o r n13St 
cells to secrete rclevant so lu ble m ed iators. Som e types of endo-
thelia l cells do synth esize and sec rete fac to rs such as pros tag landin 
E~ , pl:ltelet-activating fJctor, and intcrlcuki n I; also. the prod uc-
ti on of these types of m ediators by endotheli al ce lls ca n be en-
hanced by a va ri ety of st imuli 11 7-20 1. Alth o ugh it is not known 
w hether PMN s m od ul ate the synth esis o r secretio n ofcnd o thcli al 
cell-deri ved m ediators in vivo, thc m argination and diapedesis o f 
leukocytes at sites of C5a-induced cutaneo us inflammatio n sug-
ges t that such bio logic effects m ay result fro ll1 these cellular in-
teraction s. This invcs ti gat io n, as we ll as o ur prev ious stu d ies. has 
shown that mJst cclls play an impo rtant role in cutancous reac-
tivity to hum an C5a. We luve shown that dermal m as t cell s 
dcg ranul ate at C5a inj ectio n itcs and thJt histamin e is reI cased 
into sucti on blister fluid s co llected over these test sites in hUIl1 Jn 
skin. In the present stu dy , pat ients w ith BMF demo nstrated no r-
mal cutJneous reactivity to m o rphin e (:\ derm al m as t cell secret-
agogue), thus showing that the res po nsiveness of this criti ca l 
cellular elem ent remains intact ill thcse subj ects. Decreased cu-
taneous reactivity to CSa in patients w ith neutro peni a o r neutro-
phi l fun cti on defects sugges ts that PMNs m ake a signi fi cant and 
imm edi ate co ntri b utio n to Sa-induced cutaneous inflammation . 
Whcther thi s contributi o n is m ade directl y o r occu rs secondary 
to an effect of neut rophil s on dermal m as t cells (o r o thcr cells 
res iding in hUlll an skin ) awaits direct investigatio n . 
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